“Our DCF (discounted-cash flow) based price target assumes a risk-free rate of 1.8% and cost of equity of 14%,” explains Mak. She adds that the hold recommendation reflects FY2023 price-to-earnings of 10.7x19% net earnings growth.
SAC Capital is initiating coverage on diversified medical group Livingstone Health with a ‘hold’ call and target price of 16.8 cents.
This gives the counter a free float of 25% and is up 2.1 cents from its current 14.7 cent price, analyst Peggy Mak writes in a Feb 3 note.
